Skip to main content
×
×
Home

What every psychiatrist should know about buprenorphine in substance misuse

  • Matira Taikato (a1), Brian Kidd (a2) and Alex Baldacchino (a3)
Extract

Buprenorphine is prescribed as a treatment for opioid dependence (Barnett et al, 2001; Lintzeris et al, 2002). Methadone substitute prescribing is the primary maintenance treatment in Britain and is well established (Ward, 1997). Despite the advantages of methadone maintenance there are associated disadvantages, including potential death following overdose, the inconvenience of daily dosing, the risk of the drug being used by others and stigma (Walsh, 1994).

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      What every psychiatrist should know about buprenorphine in substance misuse
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      What every psychiatrist should know about buprenorphine in substance misuse
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      What every psychiatrist should know about buprenorphine in substance misuse
      Available formats
      ×
Copyright
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
References
Hide All
Barnett, P., Rodgers, J. & Bloch, D. (2001) A meta-analysis comparing buprenorphine to methadone for treatment of opiate dependence. Addiction, 96, 683690.
Effective Interventions Unit, Scottish Executive (2002) The Effectiveness of Treatment for Opiate Dependent Drug Users. Edinburgh: Scottish Executive. http://www.Scotland.gov.uk/library5/health/isrem-oo.asp
Ford, C., Morton, S., Lintzeris, N., et al, eds (2003) Guidance for the Use of Buprenorphine for the Treatment of Opioid Dependence in Primary Care. London: Royal College of General Practitioners.
Ghodse, A. H. & Baldacchino, A. M. (2004) Opioid Analgesics and Narcotic Antagonists: Buprenorphine. Side Effects of Drugs (ed. Aronson, J. K.), pp. 88101. Amsterdam: Elsevier.
Gowing, L., Ali, R. & White, J. (2005) Buprenorphine for the management of opioid withdrawal (Cochrane Review). The Cochrane Library issue 1. Chichester: Wiley.
Kakko, J., Svanborg, K., Kreek, M., et al (2003) A 1 year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial. Lancet, 361, 662668.
Kintz, P. (2001) Deaths involving buprenorphine: a compendium of French cases. Forensic Science International, 121, 6569.
Lavelle, T., Hammersley, R., Forsyth, A., et al (1991) The use of buprenorphine and temazepam by drug injectors. Journal of Addictive Diseases, 10, 514.
Lintzeris, N., Bell, J., Bammer, G., et al (2002) A randomised controlled trial of buprenorphine in the management of short-term ambulatory heroin withdrawal. Addiction, 97, 13951404.
Mattick, R. P., Kimber, J., Breen, C., et al (2004) Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence: a systematic review. The Cochrane Library, issue 2. Chichester: Wiley.
Petry, N., Bickel, W. K., Piasecki, D., et al (2000) Elevated liver enzyme levels in opioid-dependent patients with hepatitis treated with buprenorphine. American Journal on Addictions, 9, 265269.
Sakol, M. S., Stark, C. & Sykes, R. (1989) Buprenorphine and temazepam abuse by drug takers in Glasgow – an increase. British Journal of Addictions, 84, 439441.
Walsh, S. L., Preston, K., Stitzer, M. L., et al (1994) Clinical pharmacology of buprenorphine: ceiling effects at high doses. Clinical Pharmacology and Therapeutics, 55, 569580.
Ward, J., Mattick, R. P. & Hall, W., eds (1997) Methadone Maintenance Treatment and other Opioid Replacement Therapies. Australia: Harwood Academic.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

BJPsych Bulletin
  • ISSN: 0955-6036
  • EISSN: 1472-1473
  • URL: /core/journals/bjpsych-bulletin
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 11 *
Loading metrics...

Abstract views

Total abstract views: 57 *
Loading metrics...

* Views captured on Cambridge Core between 2nd January 2018 - 17th July 2018. This data will be updated every 24 hours.

What every psychiatrist should know about buprenorphine in substance misuse

  • Matira Taikato (a1), Brian Kidd (a2) and Alex Baldacchino (a3)
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *